Bellevue Group Ag Abb Vie Inc. Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Abb Vie Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 42,886 shares of ABBV stock, worth $7.53 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

42,886

Previous 42,204 1.62%

Holding current value

$7.53 Million

Previous $7.24 Million 17.01%

% of portfolio

0.14%

Previous 0.12%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $111,738 - $135,943	682 Added 1.62%	42,886 $8.47 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $2.26 Million - $2.64 Million	14,611 Added 52.95%	42,204 $7.24 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $3.33 Million - $3.8 Million	20,866 Added 310.18%	27,593 $5.02 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $270,246 - $304,361	1,964 Added 41.23%	6,727 $1.04 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $188,495 - $218,211	-1,411 Reduced 22.85%	4,763 $709,000
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $1.46 Million - $1.81 Million	-11,002 Reduced 64.05%	6,174 $831,000
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $141,139 - $162,543	976 Added 6.02%	17,176 $2.74 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $110,233 - $132,198	-797 Reduced 4.69%	16,200 $2.62 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $2.17 Million - $2.49 Million	16,189 Added 2003.59%	16,997 $2.28 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $42.8 Million - $54.4 Million	-310,692 Reduced 99.74%	808 $124,000
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $607,108 - $753,250	4,600 Added 1.5%	311,500 $50.5 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $2.58 Million - $3.26 Million	24,000 Added 8.48%	306,900 $41.6 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $4.39 Million - $4.99 Million	-41,300 Reduced 12.74%	282,900 $30.5 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $6.3 Million - $7.02 Million	-59,900 Reduced 15.59%	324,200 $36.5 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $879,780 - $968,532	8,600 Added 2.29%	384,100 $41.6 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $27.2 Million - $36.8 Million	338,500 Added 914.86%	375,500 $40.2 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $851,092 - $1.14 Million	11,600 Added 45.67%	37,000 $3.63 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $1.1 Million - $1.67 Million	-17,100 Reduced 40.24%	25,400 $1.94 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $3.07 Million - $3.84 Million	42,500 New	42,500 $3.76 Million
Q1 2018 May 09, 2018	SELL	$92.01 - $123.21 $1.79 Million - $2.4 Million	-19,500 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $7.46 Million - $8.18 Million	-83,277 Reduced 81.03%	19,500 $1.89 Million
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $824,020 - $1.05 Million	-11,797 Reduced 10.3%	102,777 $9.13 Million
Q2 2017 Aug 14, 2017	BUY	N/A	114,574	114,574 $8.31 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Abb Vie Inc. Transaction History